InvestorsHub Logo
Followers 0
Posts 121
Boards Moderated 0
Alias Born 03/10/2014

Re: Focusakker post# 172616

Sunday, 02/19/2017 7:48:49 PM

Sunday, February 19, 2017 7:48:49 PM

Post# of 403034
Kevetrin Questions

How many subjects in Phase 1 had Ovarian Cancer (I came across this info a while back, but can't seem to find it now)?

On CTIX Fact Sheet for Kevetrin, it states 60% of Ovarian Cancer patients had a 3%-73% increase in p21 biomarker. Was it ever stated if the percentage was correlated with dose? Is the raw data available anywhere that we can see each patient, their dose, and their response?

I'm trying to do a little research on the relationship between p21 and p53, but my non-medical background isn't helping. If anyone has a dumbed down website on it, please feel free to share.

Thanks everyone.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News